Biospecific haemosorbents based on proteinase inhibitor. III. Biospecific antiproteinase haemosorbent 'Ovosorb' in complex therapy of acute destructive pancreatitis.
Analysis was carried out of the results of complex therapy in 32 patients with acute destructive pancreatitis for which haemosorbtion on Ovosorb, a biospecific antiproteinase haemosorbent containing an immobilized ovomucoid, was used. The clinical efficiency of haemosorbtion was displayed as a decrease in gravity of endogenous intoxication and related functional and metabolic disturbances, as well as in a reduction of lethality from 24.7% to 6.2%.
Kirkovsky
V V
VV
Laboratory of Hemosorbtion of Minsk State Medical Institute, Republic of Belarus.
Antiperovich
O F
OF
Valueva
T A
TA
Moin
V M
VM
Lobacheva
G A
GA
Berezkina
O G
OG
D000208:Acute Disease; D006464:Hemoperfusion; D006801:Humans; D009102:Multiple Organ Failure / Q000628:therapy; D010059:Ovomucin / Q000627:therapeutic use*; D010195:Pancreatitis / Q000097:blood / Q000628:therapy*; D011480:Protease Inhibitors / Q000378:metabolism / Q000627:therapeutic use*
D011480:Protease Inhibitors; C073841:Ovosorb; D010059:Ovomucin